Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John E Leonard is active.

Publication


Featured researches published by John E Leonard.


Archive | 1993

Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma

Darrell R Anderson; Nabil Hanna; John E Leonard; Roland A Newman; Mitchell E Reff; William H Rastetter


International Immunopharmacology | 2001

A humanized anti-human CD154 monoclonal antibody blocks CD154–CD40 mediated human B cell activation

Peter Brams; Amelia Black; Eduardo A. Padlan; Kandasamy Hariharan; John E Leonard; Karen Chambers-Slater; Randolph J. Noelle; Roland A Newman


Clinical Immunology and Immunopathology | 1997

A PrimatizedMAb to Human CD4 Causes Receptor Modulation, without Marked Reduction in CD4+T Cells in Chimpanzees:In Vitroandin VivoCharacterization of a MAb (IDEC-CE9.1) to Human CD4☆

Darrell R Anderson; Karen Chambers; Nabil Hanna; John E Leonard; Mitchell E Reff; Roland A Newman; John Baldoni; Donna Dunleavy; Manjula Reddy; Raymond Sweet; Alemseged Truneh


Archive | 2000

Therapy using chimera antibody to human b lymphocyte limited differentiation antigen and radioactivity labelled antibody for treatment of b cell lymphoma

Darrell R Anderson; Nabil Hanna; John E Leonard; Roland A Newman; William H Rastetter; Mitchell E Reff; アール. アンダーソン,ダレル; エー. ニューマン,ローランド; ハンナ,ネイビル; エイチ. ラステッター,ウィリアム; イー. レナード,ジョン; イー. レフ,ミッチェル


Archive | 1993

Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma

Darrell R Anderson; Nabil Hanna; John E Leonard; Roland A Newman; Mitchell E Reff; William H Rastetter


Archive | 1995

Process for the production of therapeutically useful in immunologically active, chimeric, CD20-antigen-specific binding of antibodies

Nabil Hanna; William H Rastetter; John E Leonard; Roland A Newman; Darrell R Anderson; Mitchell E Reff


Archive | 1995

Terapeutisk användning av chimera och radiomärkta antikroppar mot en till humana B-lymfocyter begränsad differentieringsantigen för behandling av B-cellymfom

Darrell R Anderson; Willian H Rastetter; Nabil Hanna; John E Leonard; Roland A Newman; Mitchell E Reff


Archive | 1995

Menetelmä terapeuttisesti käyttökelpoisten, immunologisesti aktiivisten, kimeeristen, CD20-antigeenia spesifisesti sitovien vasta-aineiden tuottamiseksi

Nabil Hanna; William H Rastetter; John E Leonard; Roland A Newman; Darrell R Anderson; Mitchell E Reff


Archive | 1995

Ihmisen B-lymfosyytteihin rajoittunutta erilaistumisantigeenia vastaan kimeeristen ja radioleimattujen vasta-aineiden terapeuttinen käyttö B-solulymfooman hoitoon

Darrell R Anderson; Willian H Rastetter; Nabil Hanna; John E Leonard; Roland A Newman; Mitchell E Reff


Archive | 1995

Human B lymphocytes against erilaistumisantigeenia limited the therapeutic use of chimeric and radiolabeled antibodies for the treatment of B-cell lymphoma

Darrell R Anderson; Willian H Rastetter; Nabil Hanna; John E Leonard; Roland A Newman; Mitchell E Reff

Collaboration


Dive into the John E Leonard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Darrell R Anderson

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Nabil Hanna

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eduardo A. Padlan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Manjula Reddy

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge